Table 3.
Expression of NY-ESO-1 in primary and metastatic melanoma lesions from various organ sites
| Positive | Negative | Total | |
|---|---|---|---|
| Primary | |||
| Skin | 0 | 15 | 15 |
| Rectum/anus | 0 | 1 | 1 |
| Metastasis | |||
| Lymph node | 19 | 49 | 68 |
| Skin | 5 | 35 | 40 |
| Dermis | 2 | 13 | 15 |
| Dermis/subcutis | 3 | 17 | 20 |
| Subcutis | 0 | 5 | 5 |
| Soft tissue | 10 | 26 | 36 |
| Lung | 7 | 12 | 19 |
| GI | 6 | 11 | 17 |
| Stomach | 0 | 1 | 1 |
| Small bowel | 5 | 10 | 15 |
| Colon | 1 | 0 | 1 |
| Gallbladder | 1 | 0 | 1 |
| Liver | 3 | 3 | 6 |
| Muscle | 1 | 2 | 3 |
| Brain | 0 | 2 | 2 |
| Spleen | 2 | 1 | 3 |
| Adrenal gland | 1 | 1 | 2 |
| Bone | 1 | 1 | 2 |
| Ovary | 1 | 1 | 2 |
| Breast | 0 | 2 | 2 |
| Omentum | 1 | 0 | 1 |
| Salivary gland | 0 | 1 | 1 |
| Ureter | 0 | 1 | 1 |
| Total | 58 | 164 | 222 |